Lyra Therapeutics, Inc. (LYRA)

Lyra Therapeutics Revenue

Lyra Therapeutics had revenue of $1.68M in the twelve months ending March 31, 2024, with 28.74% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $532.00K with 29.76% year-over-year growth. In the year 2023, Lyra Therapeutics had annual revenue of $1.56M with 14.31% growth.

• Revenue (ttm): $1.68M
• Revenue Growth: +28.74%
• P/S Ratio: 186.70
• Revenue / Employee: $19,091
• Employees: 88
• Market Cap: 313.65M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.56M	195.00K	14.31%
Dec 31, 2022	1.36M	1.08M	378.25%
Dec 31, 2021	285.00K	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	1.24M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.